These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7649205)

  • 1. In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
    Berenguer J; Fernández-Baca V; Sánchez R; Bouza E
    Eur J Clin Microbiol Infect Dis; 1995 Apr; 14(4):362-5. PubMed ID: 7649205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro susceptibilities of clinical yeast isolates to three antifungal agents determined by the microdilution method.
    Pfaller MA; Barry AL
    Mycopathologia; 1995; 130(1):3-9. PubMed ID: 7666925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of macrodilution and alamar colorimetric microdilution broth methods for antifungal susceptibility testing of yeast isolates.
    To WK; Fothergill AW; Rinaldi MG
    J Clin Microbiol; 1995 Oct; 33(10):2660-4. PubMed ID: 8567901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of 119 yeast isolates to fluconazole, 5-fluorocytosine, amphotericin B and ketoconazole.
    Morace G; Manzara S; Dettori G
    Chemotherapy; 1991; 37(1):23-31. PubMed ID: 2013239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro susceptibility of yeasts for fluconazole and itraconazole. Evaluation of a microdilution test.
    Nenoff P; Oswald U; Haustein UF
    Mycoses; 1999; 42(11-12):629-39. PubMed ID: 10680439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluconazole vs amphotericin B: "in vitro" comparative evaluation of the minimal inhibitory concentration (MIC) against yeasts isolated from AIDS patients.
    Lombardi G; Gramegna G; Cavanna C; Michelone G
    Microbiologica; 1990 Jul; 13(3):201-6. PubMed ID: 2273982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
    Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
    J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In-vitro activity of 5-fluorocytosine against 1,021 Spanish clinical isolates of Candida and other medically important yeasts.
    Quindós G; Ruesga MT; Martín-Mazuelos E; Salesa R; Alonso-Vargas R; Carrillo-Muñoz AJ; Brena S; San Millán R; Pontón J
    Rev Iberoam Micol; 2004 Jun; 21(2):63-9. PubMed ID: 15538829
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility of 245 yeast isolates to amphotericin B, 5-fluorocytosine, ketoconazole, fluconazole and itraconazole.
    Martín E; Parras P; Lozano MC
    Chemotherapy; 1992; 38(5):335-9. PubMed ID: 1337508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
    Kovacicova G; Krupova Y; Lovaszova M; Roidova A; Trupl J; Liskova A; Hanzen J; Milosovic P; Lamosova M; Macekova L; Szovenyiova Z; Purgelova A; Obertik T; Bille J; Krcmery V
    J Infect Chemother; 2000 Dec; 6(4):216-21. PubMed ID: 11810569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
    Dannaoui E; Paugam A; Develoux M; Chochillon C; Matheron J; Datry A; Bouges-Michel C; Bonnal C; Dromer F; Bretagne S
    Clin Microbiol Infect; 2010 Jul; 16(7):863-9. PubMed ID: 19778296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of a new triazole, Sch 56592, compared with those of four other antifungal agents tested against clinical isolates of Candida spp. and Saccharomyces cerevisiae.
    Pfaller MA; Messer S; Jones RN
    Antimicrob Agents Chemother; 1997 Feb; 41(2):233-5. PubMed ID: 9021172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
    Rex JH; Pfaller MA; Barry AL; Nelson PW; Webb CD
    Antimicrob Agents Chemother; 1995 Jan; 39(1):40-4. PubMed ID: 7695326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro susceptibility of Trichosporon beigelii to antifungal agents.
    Perparim K; Nagai H; Hashimoto A; Goto Y; Tashiro T; Nasu M
    J Chemother; 1996 Dec; 8(6):445-8. PubMed ID: 8981185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
    Marco F; Pfaller MA; Messer SA; Jones RN
    Diagn Microbiol Infect Dis; 1998 Sep; 32(1):33-7. PubMed ID: 9791755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017).
    Desnos-Ollivier M; Bretagne S; Boullié A; Gautier C; Dromer F; Lortholary O;
    Clin Microbiol Infect; 2019 May; 25(5):634.e1-634.e4. PubMed ID: 30771532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Studies on microtiter broth dilution method for antifungal susceptibility testing of yeast isolates from blood and cerebrospinal fluid].
    Fujita S
    Rinsho Byori; 1996 Apr; 44(4):373-8. PubMed ID: 8847821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of albicans and non-albicans candiduria in a Malaysian medical centre.
    Ding CH; Wahab AA; Muttaqillah NA; Tzar MN
    J Pak Med Assoc; 2014 Dec; 64(12):1375-9. PubMed ID: 25842581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.
    Zhang J; Hollis RJ; Pfaller MA
    Diagn Microbiol Infect Dis; 1997 Mar; 27(3):63-7. PubMed ID: 9147006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.